186 related articles for article (PubMed ID: 6194137)
21. The pathogenesis and therapy of multiple sclerosis is based upon the requirement of a combination of myelin antigens for autoimmune demyelination.
Raine CS; Traugott U
J Neuroimmunol; 1982 Jan; 2(1):83-91. PubMed ID: 6185537
[TBL] [Abstract][Full Text] [Related]
22. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
Ziemssen T; Ziemssen F
Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients.
Brokstad KA; Page M; Nyland H; Haaheim LR
Acta Neurol Scand; 1994 Jun; 89(6):407-11. PubMed ID: 7526591
[TBL] [Abstract][Full Text] [Related]
24. Myelin basic protein infused into cerebrospinal fluid suppresses experimental autoimmune encephalomyelitis.
Harling-Berg CJ; Knopf PM; Cserr HF
J Neuroimmunol; 1991 Dec; 35(1-3):45-51. PubMed ID: 1720138
[TBL] [Abstract][Full Text] [Related]
25. Spinal fluid basic protein immunoreactive material and spinal fluid lymphocyte reactivity to basic protein.
Lisak RP; Zweiman B; Whitaker JN
Neurology; 1981 Feb; 31(2):180-2. PubMed ID: 6162132
[TBL] [Abstract][Full Text] [Related]
26. The role of myelin lipids in experimental allergic encephalomyelitis. Part 1. Influence on disease production by non-encephalitogenic doses of myelin basic protein.
Hosein ZZ; Gilbert JJ; Strejan GH
J Neuroimmunol; 1984 Dec; 7(2-3):163-78. PubMed ID: 6210304
[TBL] [Abstract][Full Text] [Related]
27. Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: demonstration of T cell anergy.
Jewell SD; Gienapp IE; Cox KL; Whitacre CC
Immunol Cell Biol; 1998 Feb; 76(1):74-82. PubMed ID: 9553779
[TBL] [Abstract][Full Text] [Related]
28. Treatment of experimental allergic encephalomyelitis (EAE) induced by guinea pig myelin basic protein epitope 72-85 with a human MBP(87-99) analogue and effects of cyclic peptides.
Tselios T; Daliani I; Probert L; Deraos S; Matsoukas E; Roy S; Pires J; Moore G; Matsoukas J
Bioorg Med Chem; 2000 Aug; 8(8):1903-9. PubMed ID: 11003134
[TBL] [Abstract][Full Text] [Related]
29. Antibody response to myelin basic protein: comparisons between Lewis rats with experimental allergic encephalomyelitis, and tolerant rats.
Swierkosz JE; Swanborg RH
Immunol Commun; 1977; 6(5):499-515. PubMed ID: 72724
[TBL] [Abstract][Full Text] [Related]
30. Treatment of murine experimental autoimmune encephalomyelitis with a myelin basic protein peptide analog alters the cellular composition of leukocytes infiltrating the cerebrospinal fluid.
Reiseter BS; Miller GT; Happ MP; Kasaian MT
J Neuroimmunol; 1998 Nov; 91(1-2):156-70. PubMed ID: 9846832
[TBL] [Abstract][Full Text] [Related]
31. Immunochemistry and biochemistry of myelin.
Davison AN; Cuzner ML
Br Med Bull; 1977 Jan; 33(1):60-6. PubMed ID: 64271
[No Abstract] [Full Text] [Related]
32. Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis.
Chou YK; Bourdette DN; Offner H; Whitham R; Wang RY; Hashim GA; Vandenbark AA
J Neuroimmunol; 1992 May; 38(1-2):105-13. PubMed ID: 1374422
[TBL] [Abstract][Full Text] [Related]
33. Liposomes containing myelin basic protein (BP) suppress but do not induce allergic encephalomyelitis in Lewis rats.
Willenborg DO; Higgins TJ
Aust J Exp Biol Med Sci; 1981 Apr; 59(Pt 2):135-41. PubMed ID: 6167253
[TBL] [Abstract][Full Text] [Related]
34. LT/EAE and the MS quest. Going to the dogs and rats to study the patient.
Paterson PY
Cell Immunol; 1983 Nov; 82(1):55-74. PubMed ID: 6196130
[No Abstract] [Full Text] [Related]
35. Effect of methylprednisolone on CSF IgG parameters, myelin basic protein and anti-myelin basic protein in multiple sclerosis exacerbations.
Warren KG; Catz I; Jeffrey VM; Carroll DJ
Can J Neurol Sci; 1986 Feb; 13(1):25-30. PubMed ID: 2420429
[TBL] [Abstract][Full Text] [Related]
36. Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis.
Deraos G; Rodi M; Kalbacher H; Chatzantoni K; Karagiannis F; Synodinos L; Plotas P; Papalois A; Dimisianos N; Papathanasopoulos P; Gatos D; Tselios T; Apostolopoulos V; Mouzaki A; Matsoukas J
Eur J Med Chem; 2015 Aug; 101():13-23. PubMed ID: 26112377
[TBL] [Abstract][Full Text] [Related]
37. Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis.
García-Merino A; Persson MA; Ernerudh J; Díaz-Gil JJ; Olsson T
J Neurol Neurosurg Psychiatry; 1986 Sep; 49(9):1066-70. PubMed ID: 2428940
[TBL] [Abstract][Full Text] [Related]
38. B-cell responses to myelin basic protein and its epitopes in autoimmune encephalomyelitis induced by Semple rabies vaccine.
Piyasirisilp S; Hemachudha T; Griffin DE
J Neuroimmunol; 1999 Aug; 98(2):96-104. PubMed ID: 10430042
[TBL] [Abstract][Full Text] [Related]
39. A myelin basic protein antibody cascade in purified IgG from cerebrospinal fluid of multiple sclerosis patients.
Warren KG; Catz I
J Neurol Sci; 1990 Apr; 96(1):19-27. PubMed ID: 1693669
[TBL] [Abstract][Full Text] [Related]
40. [Mechanisms involved in the regulation of immune response in experimental autoimmune encephalomyelitis in mice].
Tutaj M; Szczepanik M
Postepy Hig Med Dosw (Online); 2006; 60():571-83. PubMed ID: 17115007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
